
Crystal commemorative celebrating the submission to the FDA of a New Drug Application (NDA). INP104 is intended for the acute treatment of migraine headaches. (20ALJ356)
Crystal commemorative celebrating the submission to the FDA of a New Drug Application (NDA). INP104 is intended for the acute treatment of migraine headaches. (20ALJ356)
"*" indicates required fields
Coming up with unique award and gift ideas for the oil industry can be a challenge. Many of the traditional concepts may seem tired and unlikely to have considerable perceived value. These include, for instance, the many variations of brass pump...
Logo-themed designs tend to be a frequent suggestion for custom corporate awards. After all, the perceived value and cachet of custom awards lies in their distinctive design elements. And logos, because they are by definition distinctive, offer a...
With the run-up to Super Bowl LV on Sunday, February 7th, we thought we'd update a post focusing on a Lucite embedment that resulted from an earlier Super Bowl game. No, the Philadelphia Eagles won't be going to the game this year; but the Kansas...